Literature DB >> 12535646

A third human carnitine/organic cation transporter (OCTN3) as a candidate for the 5q31 Crohn's disease locus (IBD5).

Anne-Marie Lamhonwah1, Jennifer Skaug, Stephen W Scherer, Ingrid Tein.   

Abstract

Organic cation transporters function primarily in the elimination of cationic drugs in kidney, intestine, and liver. The murine organic cation/carnitine (Octn) transporter family, Octn1, Octn2, and Octn3 is clustered on mouse chromosome 11 (NCBI Accession No. NW_000039). The human OCTN1 and OCTN2 orthologs map to the syntenic IBD5 locus at 5q31, which has been shown to confer susceptibility to Crohn's disease. We show that the human OCTN3 protein, whose corresponding gene is not yet cloned or annotated in the human reference DNA sequence, does indeed exist and is uniquely involved in carnitine-dependent transport in peroxisomes. Its functional properties and inferred chromosomal location implicate it for involvement in Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12535646     DOI: 10.1016/s0006-291x(02)02946-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  OCTN2 mutation (R254X) found in Saudi Arabian kindred: recurrent mutation or ancient founder mutation?

Authors:  A-M Lamhonwah; R Onizuka; S E Olpin; F Muntoni; I Tein
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

2.  CARNITINE HOMEOSTASIS, MITOCHONDRIAL FUNCTION, AND CARDIOVASCULAR DISEASE.

Authors:  Shruti Sharma; Stephen M Black
Journal:  Drug Discov Today Dis Mech       Date:  2009

3.  Single nucleotide polymorphisms of OCTN1, OCTN2, and DLG5 genes in Greek patients with Crohn's disease.

Authors:  Maria Gazouli; Gerassimos Mantzaris; Athanassios J Archimandritis; George Nasioulas; Nicholas P Anagnou
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

4.  Effects of doxorubicin-containing chemotherapy and a combination with L-carnitine on oxidative metabolism in patients with non-Hodgkin lymphoma.

Authors:  Raimund Waldner; Claudia Laschan; Alfred Lohninger; Martin Gessner; Heinz Tüchler; Marlies Huemer; Wolfgang Spiegel; Heidrun Karlic
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-08       Impact factor: 4.553

Review 5.  Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature.

Authors:  Patricia Sarlos; Erzsebet Kovesdi; Lili Magyari; Zsolt Banfai; Andras Szabo; Andras Javorhazy; Bela Melegh
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

Review 6.  Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ?

Authors:  Peter Laszlo Lakatos; Simon Fischer; Laszlo Lakatos; Istvan Gal; Janos Papp
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

7.  Alpha-tocopherol beta-oxidation localized to rat liver mitochondria.

Authors:  Debbie J Mustacich; Scott W Leonard; Neha K Patel; Maret G Traber
Journal:  Free Radic Biol Med       Date:  2009-10-09       Impact factor: 7.376

Review 8.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

9.  PREGABALIN TREATMENT OF PERIPHERAL NERVE DAMAGE IN A MURINE DIABETIC PERIPHERAL NEUROPATHY MODEL.

Authors:  J Li; X Chen; X Lu; C Zhang; Q Shi; L Feng
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jul-Sep       Impact factor: 0.877

Review 10.  The Mystery of Extramitochondrial Proteins Lysine Succinylation.

Authors:  Christos Chinopoulos
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.